Antibody-drug conjugates in lung cancer: dawn of a new era?

Antibody-drug conjugates (ADCs) are one of fastest growing classes of oncology drugs in modern drug development. By harnessing the powers of both cytotoxic chemotherapy and targeted therapy, ADCs are unique in offering the potential to deliver highly potent cytotoxic agents to cancer cells which exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Coleman, Niamh, Yap, Timothy A., Heymach, John V., Meric-Bernstam, Funda, Le, Xiuning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834242/
https://www.ncbi.nlm.nih.gov/pubmed/36631624
http://dx.doi.org/10.1038/s41698-022-00338-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834242/
https://www.ncbi.nlm.nih.gov/pubmed/36631624
http://dx.doi.org/10.1038/s41698-022-00338-9

Ejemplares similares